BerandaCYBN • NYSEAMERICAN
add
Cybin Inc
$7,52
Sebelum Jam Perdagangan Normal:(0,13%)+0,010
$7,53
Tutup: 17 Jul, 04.07.51 GMT-4 · USD · NYSEAMERICAN · Pernyataan Penyangkalan
Tutup sebelumnya
$7,41
Rentang hari
$7,33 - $7,55
Rentang tahun
$4,81 - $13,88
Volume Rata-Rata
369,01Â rb
Rasio P/E
-
Hasil dividen
-
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CAD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 33,24Â jt | 31,95% |
Laba bersih | -30,58Â jt | -43,25% |
Margin laba bersih | — | — |
Penghasilan per saham | -1,46 | -92,14% |
EBITDA | -33,19Â jt | -32,03% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (CAD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 135,02Â jt | -35,39% |
Total aset | 258,62Â jt | -14,37% |
Total liabilitas | 21,42Â jt | 112,14% |
Total ekuitas | 237,20 jt | — |
Saham yang beredar | 23,03 jt | — |
Harga terhadap nilai buku | 0,67 | — |
Tingkat pengembalian aset | -32,45% | — |
Tingkat pengembalian modal | -34,81% | — |
Arus Kas
Perubahan kas bersih
| (CAD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -30,58Â jt | -43,25% |
Kas dari operasi | -21,11Â jt | -1,96% |
Kas dari investasi | -1,08Â jt | -404,19% |
Kas dari pembiayaan | 20,98Â jt | -89,01% |
Perubahan kas bersih | -1,27Â jt | -100,75% |
Arus kas bebas | -11,14Â jt | 12,30% |
Tentang
Cybin IRL is a Canadian pharmaceutical company that is developing psychedelic drugs as medicines.
The company's drug candidates include psilocybin, CYB002, CYB003, CYB004, CYB005, and CYB006. Another drug that the company has developed is CYB210010.
As of January 2025, CYB003 is in phase 3 clinical trials. The drug is one of the only other psychedelics besides Compass Pathways's COMP360 to have reached this late stage of clinical development.
In 2020, Cybin acquired psychedelic pharmaceutical company Adelia Therapeutics. Wikipedia
Didirikan
2019
Kantor pusat
Situs
Karyawan
50
